WisdomTree BioRevolution Fund
WDNA
6 hedge funds and large institutions have $1.97M invested in WisdomTree BioRevolution Fund in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.
104.87% more ownership
Funds ownership: 121.89% → 226.76% (+105%)
60% more capital invested
Capital invested by funds: $1.23M → $1.97M (+$735K)
14% less funds holding
Funds holding: 7 → 6 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$471K |
| 2 |
Jane Street
New York
|
+$280K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$219K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$9.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10K |
| 3 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$6K |
WDNA Hedge Fund Activity: Q2 2022 in Review
6 institutional investors reported a position in WisdomTree BioRevolution Fund (WDNA) for Q2 2022, worth a combined $1.97M — up 60% from $1.23M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of WDNA and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Flow Traders U.S., adding an estimated $471K. The largest seller was UBS Group, exiting entirely with an estimated $18K sold.
- 6 institutional investors held WisdomTree BioRevolution Fund (WDNA) as of Q2 2022, down from 7 in Q1 2022.
- Funds reported $1.97M of WisdomTree BioRevolution Fund stock for Q2 2022, up 60% quarter-over-quarter.
- 2 funds opened new WisdomTree BioRevolution Fund positions in Q2 2022 and 3 closed out, a net change of -1 holder.
- The largest WisdomTree BioRevolution Fund buyer in Q2 2022 was Flow Traders U.S., an estimated $471K added.
- The largest WisdomTree BioRevolution Fund seller in Q2 2022 was UBS Group, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2022.